Page last updated: 2024-08-16

temozolomide and n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester

temozolomide has been researched along with n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Daou, MC; Gilbert, CA; Moser, RP; Ross, AH	1

Other Studies

1 other study(ies) available for temozolomide and n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester

Article	Year
Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence. Cancer research, 2010, Sep-01, Volume: 70, Issue:17 Topics: Amyloid Precursor Protein Secretases; Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Dipeptides; Glioblastoma; Humans; Mice; Neoplasm Recurrence, Local; Receptors, Notch; RNA, Messenger; Signal Transduction; Spheroids, Cellular; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2010

Article

Year

Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence.

Cancer research, 2010, Sep-01, Volume: 70, Issue:17

Topics: Amyloid Precursor Protein Secretases; Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Dipeptides; Glioblastoma; Humans; Mice; Neoplasm Recurrence, Local; Receptors, Notch; RNA, Messenger; Signal Transduction; Spheroids, Cellular; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2010